Unassociated Document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549

FORM 10-Q
( MARK ONE )

x
Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2009.

OR

¨
Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from ___________to ________.

Commission File No. 0-16469

INTER PARFUMS, INC.
(Exact name of registrant as specified in its charter)

Delaware
 
13-3275609
(State or other jurisdiction of
 
(I.R.S. Employer
incorporation or organization)
  
Identification No.)

551 Fifth Avenue, New York, New York
 
10176
(Address of Principal Executive Offices)
 
(Zip Code)

(212) 983-2640
(Registrants telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes ¨ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definition of “large accelerated filer,” “accelerated filer” and “smaller reporting company”  in Rule 12b-2 of the Exchange Act).

Large accelerated Filer ¨
Accelerated filer x
Non-accelerated filer ¨ (Do not check if a smaller reporting company)
Smaller reporting company ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ¨ No x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

At November 6, 2009, there were 30,079,589 shares of common stock, par value $.001 per share, outstanding.
 
 

 
INTER PARFUMS, INC. AND SUBSIDIARIES

INDEX

     
Page Number
Part I.
Financial Information
1
       
 
Item 1.
Financial Statements
 
       
   
Consolidated Balance Sheets as of September 30, 2009 (unaudited) and December 31, 2008
2
       
   
Consolidated Statements of Income for the Three and Nine Month Periods Ended September 30, 2009 (unaudited) and September 30, 2008 (unaudited)
3
       
   
Consolidated Statements of Changes in Equity for the Nine Months Ended September 30, 2009 (unaudited) and September 30, 2008 (unaudited)
4
       
   
Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2009 (unaudited) and September 30, 2008 (unaudited)
5
       
   
Notes to Consolidated Financial Statements
6
       
 
Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
  15
       
 
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
  29
       
 
Item 4.
Controls and Procedures
  30
       
Part II.   
Other Information
  31
       
 
Item 6.
Exhibits
  31
     
 
Signatures
  31

 

 
INTER PARFUMS, INC. AND SUBSIDIARIES

Part I. Financial Information

Item 1. Financial Statements

In our opinion, the accompanying unaudited consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) necessary to present fairly our financial position, results of operations and cash flows for the interim periods presented.  We have condensed such financial statements in accordance with the rules and regulations of the Securities and Exchange Commission.  Therefore, such financial statements do not include all disclosures required by accounting principles generally accepted in the United States of America.  These financial statements should be read in conjunction with our audited financial statements for the year ended December 31, 2008 included in our annual report filed on Form 10-K.

The results of operations for the nine months ended September 30, 2009 are not necessarily indicative of the results to be expected for the entire fiscal year.

 
Page 1

 
INTER PARFUMS, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS
(In thousands except share and per share data)

   
September 30,
2009
   
December 31,
2008
 
   
(unaudited)
       
ASSETS
           
Current assets:
           
Cash and cash equivalents
  $ 57,710     $ 42,404  
Accounts receivable, net
    127,296       120,507  
Inventories
    95,998       123,633  
Receivables, other
    4,791       2,904  
Other current assets
    9,392       10,034  
Income tax receivable
    46       1,631  
Deferred tax assets
    4,880       3,388  
Total current assets
    300,113       304,501  
Equipment and leasehold improvements, net
    9,197       7,670  
Goodwill
    5,747       5,470  
Trademarks, licenses and other intangible assets, net
    105,375       104,922  
Other assets
    1,003       2,574  
Total assets
  $ 421,435     $ 425,137  
                 
LIABILITIES AND EQUITY
               
Current liabilities:
               
Loans payable – banks
  $ 10,029     $ 13,981  
Current portion of long-term debt
    11,870       13,352  
Accounts payable - trade
    40,275       66,236  
Accrued expenses
    40,063       35,368  
Income taxes payable
    1,723       442  
Dividends payable
    992       996  
Total current liabilities
    104,952       130,375  
Long-term debt, less current portion
    20,231       27,691  
Deferred tax liability
    11,013       11,562  
Equity:
               
Inter Parfums, Inc. shareholders’ equity:
               
Preferred stock, $.001 par; authorized 1,000,000 shares; none issued
               
Common stock, $.001 par; authorized 100,000,000 shares; outstanding 30,066,239 and 30,168,939 shares at September 30, 2009 and December 31, 2008, respectively
      30         30  
Additional paid-in capital
    42,478       41,950  
Retained earnings
    182,111       168,025  
Accumulated other comprehensive income
    35,602       25,515  
Treasury stock, at cost, 10,074,479 and 9,966,379 common shares at September 30, 2009 and December 31, 2008, respectively
    (31,950 )     (31,319 )
Total Inter Parfums, Inc. shareholders’ equity
    228,271       204,201  
Noncontrolling interest
    56,968       51,308  
Total equity
    285,239       255,509  
Total liabilities and equity
  $ 421,435     $ 425,137  

See notes to consolidated financial statements.

 
Page 2

 
INTER PARFUMS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME
(In thousands except per share data)
(Unaudited)

   
Three Months Ended
September 30,
   
Nine Months Ended
September 30,
 
   
2009
   
2008
   
2009
   
2008
 
                         
Net sales
  $ 117,542     $ 123,531     $ 296,555     $ 345,772  
                                 
Cost of sales
    50,462       56,206       125,709       148,385  
                                 
Gross margin
    67,080       67,325       170,846       197,387  
                                 
Selling, general and administrative
    53,169       56,039       139,812       160,124  
                                 
Income from operations
    13,911       11,286       31,034       37,263  
                                 
Other expenses (income):
                               
Interest expense
    482       1,418       2,192       2,865  
(Gain) loss on foreign currency
    (854 )     77       (4,796 )     262  
Interest income
    (135 )     (446 )     (745 )     (1,611 )
                                 
      (507 )     1,049       (3,349 )     1,516  
                                 
Income before income taxes
    14,418       10,237       34,383       35,747  
                                 
Income taxes
    4,807       2,358       11,763       12,241  
                                 
Net income
    9,611       7,879       22,620       23,506  
                                 
Less:  Net income attributable to the noncontrolling interest
    2,349       1,691       5,704       4,838  
                                 
Net income attributable to Inter Parfums, Inc.
  $ 7,262     $ 6,188     $ 16,916     $ 18,668  
                                 
Earnings per share:
                               
                                 
Net income attributable to Inter Parfums, Inc. common shareholders:
                               
Basic
  $ 0.24     $ 0.20     $ 0.56     $ 0.61  
Diluted
  $ 0.24     $ 0.20     $ 0.56     $ 0.60  
                                 
Weighted average number of shares outstanding:
                               
Basic
    30,061       30,632       30,097       30,660  
Diluted
    30,065       30,886       30,098       30,869  
                                 
Dividends declared per share
  $ 0.033     $ 0.033     $ 0.099     $ 0.099  

See notes to consolidated financial statements.

 
Page 3

 
INTER PARFUMS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
(In thousands)

   
Inter Parfums, Inc. shareholders
             
                     
Accumulated
                   
         
Additional
         
other
                   
   
Common
   
paid-in
   
Retained
   
comprehensive
   
Treasury
   
Noncontrolling
       
   
stock
   
Capital
   
earnings
   
income
   
stock
   
interest
   
Total
 
Balance – January 1, 2008
  $ 31     $ 40,023     $ 147,995     $ 30,955     $ (26,344 )   $ 53,925     $ 246,585  
Comprehensive income:
                                                       
Net income
                18,668                   4,838       23,506  
Foreign currency translation adjustment
                      (5,436 )                 (5,436 )
Net derivative instrument gain, net of tax
                      (140 )           (53 )     (193 )
Purchase of subsidiary shares from noncontrolling interests
                                  (8,623 )     (8,623 )
Sale of subsidiary shares to noncontrolling interests
          215                         1,700       1,915  
Foreign currency translation adjustment
                                  (1,307 )     (1,307 )
Dividends
                (3,043 )                 (1,735 )     (4,778 )
Purchased treasury stock
                            (2,206 )           (2,206 )
Shares issued upon exercise of stock options
          479                               479  
Stock compensation
          335       243                   105       683  
Balance – September 30, 2008
  $ 31     $ 41,052     $ 163,863     $ 25,379     $ (28,550 )   $ 48,850     $ 250,625  
                                                         
Balance – January 1, 2009
  $ 30     $ 41,950     $ 168,025     $ 25,515     $ (31,319 )   $ 51,308     $ 255,509  
Comprehensive income:
                                                       
Net income
                16,916                   5,704       22,620  
Foreign currency translation adjustment
                      13,251                   13,251  
Net derivative instrument gain, net of tax
                      (3,164 )           (1,084 )     (4,248 )
Sale of subsidiary shares to noncontrolling interests
            (53 )                             2,677       2,624  
Dividends
                (2,979 )                 (1,716 )     (4,695 )
Purchased treasury stock
                            (631 )           (631 )
Shares issued upon exercise of stock options
          200                               200  
Stock compensation
          381       149                   79       609  
Balance – September 30, 2009
  $ 30     $ 42,478     $ 182,111     $ 35,602     $ (31,950 )   $ 56,968     $ 285,239  

See notes to consolidated financial statements.

 
Page 4

 
INTER PARFUMS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)

   
Nine months ended
September 30,
 
   
2009
   
2008
 
Cash flows from operating activities:
           
Net income
  $ 22,620     $ 23,506  
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
               
Depreciation and amortization
    7,758       7,666  
Provision for doubtful accounts
    947       323  
Noncash stock compensation
    724       868  
Deferred tax (benefit)
    (2,385 )     (709 )
Change in fair value of derivatives
    (713 )      
Changes in:
               
Accounts receivable
    (1,880 )     (27,707 )
Inventories
    30,891       (32,239 )
Other assets
    (4,694 )     2,601  
Accounts payable and accrued expenses
    (24,530 )     (10,966 )
Income taxes payable, net
    4,851       (4,452 )
Net cash provided by (used in) operating activities
    33,589       (41,109 )
                 
Cash flows from investing activities:
               
Purchases of short-term investments
          (5,312 )
Proceeds from sale of  short-term investments
          5,312  
Purchases of equipment and leasehold improvements
    (3,758 )     (2,301 )
Payment for intangible assets acquired
    (622 )     (1,015 )
Payment for purchase of subsidiary shares from noncontrolling interest
          (18,405 )
Proceeds from sale of subsidiary shares to noncontrolling interest
    2,608       2,094  
Net cash used in investing activities
    (1,772 )     (19,627 )
                 
Cash flows from financing activities:
               
Proceeds (repayments) of loans payable – bank, net
    (4,025 )     20,572  
Repayment of long-term debt
    (10,360 )     (12,637 )
Proceeds from exercise of options including tax benefits
    200       479  
Dividends paid
    (2,979 )     (3,058 )
Dividends paid to noncontrolling interest
    (1,716 )     (1,735 )
Purchase of treasury stock
    (631 )     (2,206 )
Net cash provided by (used in) financing activities
    (19,511 )     1,415  
                 
Effect of exchange rate changes on cash
    3,000       1,268  
                 
Net increase (decrease) in cash and cash equivalents
    15,306       (58,053 )
                 
Cash and cash equivalents - beginning of period
    42,404       90,034  
                 
Cash and cash equivalents - end of period
  $ 57,710     $ 31,981  
                 
Supplemental disclosure of cash flow information:
               
Cash paid for:
               
Interest
  $ 2,000     $ 2,866  
Income taxes
    9,746       12,346  

See notes to consolidated financial statements

 
Page 5

 
INTER PARFUMS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

1.
Significant Accounting Policies:

The accounting policies we follow are set forth in the notes to our financial statements included in our Form 10-K which was filed with the Securities and Exchange Commission for the year ended December 31, 2008. We also discuss such policies in Part I, Item 2, Management’s Discussion and Analysis of Financial Condition and Results of Operations, included in this Form 10-Q.

2.
Recently Issued Accounting Pronouncements:

In December 2007, the FASB issued Accounting Standards Codification (“ASC”) topic 810-10-65-1 (formerly SFAS No. 160, “Noncontrolling Interests in Consolidated Financial Statements”). ASC topic 810-10-65-1 establishes requirements for ownership interests in subsidiaries held by parties other than the Company (sometimes called “minority interests”) be clearly identified, presented, and disclosed in the consolidated statement of financial position within equity, but separate from the parent’s equity. All changes in the parent’s ownership interests are required to be accounted for consistently as equity transactions and any noncontrolling equity investments in deconsolidated subsidiaries must be measured initially at fair value. ASC topic 810-10-65-1 is effective, on a prospective basis, for fiscal years beginning after December  15, 2008. The adoption by the Company of ASC topic 810-10-65-1 did not have a material impact on its consolidated financial statements. However, presentation and disclosure requirements of ASC topic 810-10-65-1 were retrospectively applied to the Company’s consolidated financial statements.

In May 2009, the FASB issued ASC topic 855 (formerly SFAS No. 165, “Subsequent Events”). ASC topic 855 provides guidance on management’s assessment of subsequent events and incorporates this guidance into accounting literature. ASC topic 855 is effective prospectively for interim and annual periods ending after June 15, 2009.

In June 2009, the FASB issued ASC topic 810 (formerly SFAS No. 167, “Amendments to FASB Interpretation No. 46(R)”). ASC topic 810 amends the consolidation guidance applicable to variable interest entities and affects the overall consolidation analysis.  ASC topic 810 is effective for fiscal years beginning after November 15, 2009. We do not believe that the adoption of ASC topic 810 will have a material impact on our consolidated financial statements.

In June 2009, the FASB issued ASC topic 105 (formerly SFAS No. 168, “The FASB Accounting Standards Codification and the Hierarchy of Generally Accepted Accounting Principles”).  ASC 105 contains guidance which reduces the U.S. GAAP hierarchy to two levels, one that is authoritative and one that is not.  ASC topic 105 is effective for financial statements issued for interim and annual periods ending after September 15, 2009. The adoption of this pronouncement did not have a material impact on our consolidated financial statements.

There are no other new accounting pronouncements issued but not yet adopted that would have a material effect on our consolidated financial statements.

 
Page 6

 
INTER PARFUMS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

3.
Inventories:

Inventories consist of the following:

(In thousands)
 
September 30,
2009
   
December 31,
2008
 
             
Raw materials and component parts
  $ 24,060     $ 37,248  
Finished goods
    71,938       86,385  
                 
    $ 95,998     $ 123,633  

4.
Fair Value Measurement:

The carrying amount of cash and cash equivalents, short-term investments, accounts receivable, other receivables, accounts payable and accrued expenses approximates fair value due to the short terms to maturity of these instruments. The carrying amount of loans payable approximates fair value as the interest rates on the Company’s indebtedness approximate current market rates. The fair value of the Company’s long-term debt was estimated based on the current rates offered to companies for debt with the same remaining maturities and is approximately equal to its carrying value.
 
Foreign currency forward exchange contracts are valued based on quotations from financial institutions and the value of interest rate swaps are the discounted net present value of the swaps using quotes obtained from financial institutions.
 
The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.
 
(In thousands)
       
Fair Value Measurements at September 30, 2009
 
         
Quoted Prices in
   
Significant Other
   
Significant
 
         
Active Markets for
   
Observable
   
Unobservable
 
         
Identical Assets
   
Inputs
   
Inputs
 
   
Total
   
(Level 1)
   
(Level 2)
   
(Level 3)
 
Assets:
                       
Money market funds
  $ 20,591     $ 20,591     $     $  
Foreign currency forward exchange contracts accounted for using hedge accounting
    2,310             2,310        
Foreign currency forward exchange contracts not accounted for using hedge accounting
    3,138             3,138        
                                 
    $ 26,039     $ 20,591     $ 5,448     $  
Liabilities:
                               
Interest rate swaps
  $ 920     $     $ 920     $  

 
Page 7

 
INTER PARFUMS, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements

(In thousands)
       
Fair Value Measurements at December 31, 2008
 
         
Quoted Prices in
   
Significant Other
   
Significant
 
         
Active Markets for
   
Observable
   
Unobservable
 
         
Identical Assets
   
Inputs
   
Inputs
 
   
Total
   
(Level 1)
   
(Level 2)
   
(Level 3)
 
Assets:
                       
Money market funds
  $ 19,816     $ 19,816     $     $  
Foreign currency forward exchange contracts accounted for using hedge accounting
    8,162             8,162        
                                 
    $ 27,978     $ 19,816     $ 8,162     $  
Liabilities:
                               
Foreign currency forward exchange contracts not accounted for using hedge accounting
  $ 1,429     $     $ 1,429     $  
Interest rate swaps
    811             811        
                                 
    $ 2,240     $     $ 2,240     $  
 
The following tables present gains and losses in derivatives designated as hedges and the location of those gains and losses in the financial statements (in thousands):
 
Derivatives in
Cash Flow
Hedging
Relationships
    Amount of Gain
(Loss) Recognized
in OCI on
Derivative
(Effective Portion)
   
Location of Gain
(Loss) Reclassified
from Accumulated
OCI into Income
(Effective Portion)
   Amount of Gain
(Loss) Reclassified
from Accumulated
OCI into Income
(Effective Portion)
 
Location of Gain
(Loss)
Recognized in
Income on
Derivative
(Effective
Portion)
    Amount of Gain
(Loss) Recognized
in Income on
Derivative
(Effective Portion)
(A)
 
   
Nine months ended
September 30,
       Nine months ended
September 30,
       Nine months ended
September 30,
 
   
2009
   
2008
     
2009
    2008      
2009
   
2008
 
Foreign exchange contracts
  $ 1,857        —  
Gain (loss) on foreign currency
  $ 4,725      
 
Gain (loss) on foreign currency
  $ 713        

 
(A) The amount of gain (loss) recognized in income represents $713 related to the amount excluded from the assessment of hedge effectiveness.
 
Derivatives in
Cash Flow
Hedging
Relationships
 
Amount of Gain
(Loss) Recognized
in OCI on
Derivative
(Effective Portion)
 
Location of Gain
(Loss) Reclassified
from Accumulated
OCI into Income
(Effective Portion)
 
Amount of Gain
(Loss) Reclassified
from Accumulated
OCI into Income
(Effective Portion)
 
Location of Gain
(Loss)
Recognized in
Income on
Derivative
(Effective
Portion)
 
Amount of Gain
(Loss) Recognized
in Income on
Derivative
(Effective Portion)
(A)
 
   
Three months ended
     
Three months ended
     
Three months ended
 
   
September 30,
     
September 30,
     
September 30,
 
   
2009
   
2008
     
2009
   
2008
     
2009
   
2008
 
Foreign exchange
           
Gain (loss) on
           
Gain (loss) on
           
contracts
  $ 2,295        
foreign currency
  $ 1,534        
foreign currency
  $ 11        
 
(A) The amount of gain (loss) recognized in income represents $11 related to the amount excluded from the assessment of hedge effectiveness. 

 
Page 8

 
INTER PARFUMS, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements
 
The following tables present gains and losses in derivatives not designated as hedges and the location of those gains and losses in the financial statements (in thousands):
 
Derivatives not
Designated as Hedging
Instruments
 
Location of Gain (Loss)
Recognized in Income on
Derivative
 
Nine months
ended
September 30,
2009
   
Nine months
ended
September 30,
2008
 
                 
Interest rate swaps
 
Interest (expense)
  $ (62 )   $ (26 )
Foreign exchange contracts
 
Gain (loss) on foreign currency
  $ 29     $ (209 )
 
Derivatives not
Designated as Hedging
Instruments
 
Location of Gain (Loss)
Recognized in Income on
Derivative
 
Three months
ended
September 30,
2009
   
Three months
ended
September 30,
2008
 
                 
Interest rate swaps
 
Interest (expense)
  $ 43     $ (394 )
Foreign exchange contracts
 
Gain (loss) on foreign currency
  $ 5     $ (541 )
 
All derivative instruments are reported as either assets or liabilities on the balance sheet measured at fair value. The valuation of interest rate swaps resulted in a liability which is included in accrued expenses on the accompanying balance sheet as of September 30, 2009. The valuation of foreign currency forward exchange contracts accounted for using hedge accounting and not accounted for using hedge accounting resulted in assets which are included in other current assets on the accompanying balance sheet as of September 30, 2009. Generally, increases or decreases in the fair value of derivative instruments will be recognized as gains or losses in earnings in the period of change. If the derivative instrument is designated and qualifies as a cash flow hedge, the changes in fair value of the derivative instrument will be recorded as a separate component of shareholders’ equity.
 
The Company enters into foreign currency forward exchange contracts to hedge exposure related to receivables denominated in a foreign currency and to manage risks related to future sales expected to be denominated in a foreign currency. Before entering into a derivative transaction for hedging purposes, it is determined that a high degree of initial effectiveness exists between the change in value of the hedged item and the change in the value of the derivative instrument from movement in exchange rates. High effectiveness means that the change in the cash flows of the derivative instrument will effectively offset the change in the cash flows of the hedged item. The effectiveness of each hedged item is measured throughout the hedged period and is based on the dollar offset methodology and excludes the portion of the fair value of the foreign currency forward exchange contract attributable to the change in spot-forward difference which is reported in current period earnings. Any hedge ineffectiveness as defined by ASC topic 815-10-10 (formerly SFAS No. 133) is also recognized as a gain or loss on foreign currency in the income statement. For hedge contracts that are no longer deemed highly effective or when the underlying forecasted transaction occurs, hedge accounting is discontinued and gains and losses accumulated in other comprehensive income are reclassified to earnings. If it is probable that the forecasted transaction will no longer occur, then any gains or losses accumulated in other comprehensive income are reclassified to current-period earnings. As of September 30, 2009, cash-flow hedges were highly effective, in all material respects.

 
Page 9

 
INTER PARFUMS, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements
 
As a result of the dramatic strengthening of the U.S. dollar, during our fourth quarter ended December 31, 2008, we entered into foreign currency forward exchange contracts to hedge approximately 80% of our 2009 sales expected to be invoiced in U.S. dollars. At September 30, 2009, we had foreign currency contracts in the form of forward exchange contracts in the amount of approximately U.S. $42.4 million and GB pounds 6.6 million which all have maturities of less than one year.

5.
Goodwill and Other Intangible Assets:

The Company reviews goodwill and trademarks with indefinite lives for impairment at least annually, and whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The following table presents our assets and liabilities that are measured at fair value on a nonrecurring basis and are categorized using the fair value hierarchy.

(In thousands)
       
Fair Value Measurements at September 30, 2009
 
         
Quoted Prices in
   
Significant Other
   
Significant
 
         
Active Markets for
   
Observable
   
Unobservable
 
         
Identical Assets
   
Inputs
   
Inputs
 
   
Total
   
(Level 1)
   
(Level 2)
   
(Level 3)
 
Description:
                       
Trademark - Nickel
  $ 2,839     $     $     $ 2,839  
 
                               
Goodwill
  $ 5,747     $     $     $ 5,747  

 
The goodwill and trademarks referred to above, relates to our Nickel skin care business which is primarily a component of our European operations. Nickel brand product sales, which performed in line with our budgets during the three month period ended September 30, 2009, had performed below our expectations in the past, and as a result, we have been reviewing goodwill and trademarks with indefinite lives relating to Nickel for impairment on a quarterly basis. We have measured fair value of goodwill as a multiple of sales applied to the average of 2008 actual sales and projected sales for 2009 and 2010. The sales multiple was based on a third party financial institution study of sales multiples for all transactions in the skin care, perfume and cosmetic sectors during the past four years. There was no change to the carrying amount of the goodwill during the nine month period ended September 30, 2009 other than for the effect of foreign currency translation rates. For indefinite-lived intangible assets, if the carrying value of an indefinite-lived intangible asset exceeds its fair value, as generally estimated using discounted future net cash flow projections and discounted terminal values, the carrying value of the asset is reduced to its fair value. During the three month period ended September 30, 2009, no impairment charges were recorded. For the nine month period ended September 30, 2009, an impairment charge relating to the Nickel trademark in the amount of $0.26 million was recorded.

6.
Shareholders’ Equity:

As of December 31, 2008, the Company’s board of directors authorized the repurchase of up to 1,031,863 shares of the Company’s common stock. During the nine month period ended September 30, 2009, the Company repurchased 108,100 shares of its common stock at an average price of $5.84 per common share.

 
Page 10

 
INTER PARFUMS, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements
 
7.
Share-Based Payments:

The Company maintains a stock option program for key employees, executives and directors. The plans, all of which have been approved by shareholder vote, provide for the granting of both nonqualified and incentive options.  Options granted under the plans typically have a six year term and vest over a four to five-year period. The fair value of shares vested during the nine month periods ended September 30, 2009 and 2008 aggregated $0.05 million and $0.02 million, respectively.

Compensation cost is recognized on a straight-line basis over the requisite service period for the entire award. It is generally the Company’s policy to issue new shares upon exercise of stock options. The following table sets forth information with respect to nonvested options for the nine month period ended September 30, 2009:
 
   
Number of Shares
   
Weighted Average Grant
Date Fair Value
 
Nonvested options – beginning of period
    490,263     $ 3.81  
Nonvested options granted
    4,000     $ 1.92  
Nonvested options vested or forfeited
    (18,990 )   $ 3.73  
Nonvested options – end of period
    475,273     $ 3.79  

Share-based payment expense decreased income before income taxes by $0.22 million and $0.72 million for the three and nine month periods ended September 30, 2009, respectively, as compared to $0.28 million and $0.87 million for the corresponding periods of the prior year.  Share-based payment expense decreased income attributable to Inter Parfums, Inc. by $0.13 million and $0.41 million for the three and nine month periods ended September 30, 2009, respectively, as compared to $0.15 million and $0.48 million for the corresponding periods of the prior year.  The following table summarizes stock option information for the nine month period ended September 30, 2009:

   
Number of Shares
   
Weighted Average
Exercise Price
 
             
Options outstanding - beginning of period
    1,138,375     $ 11.23  
Options granted
    4,000       6.15  
Options exercised
    (5,400 )     10.11  
Options forfeited or expired
    (57,000 )     15.02  
                 
Options outstanding - end of period
    1,079,975     $ 11.02  
                 
Options exercisable at September 30, 2009
    604,703     $ 10.76  
Options available for future grants
    1,266,369          

As of September 30, 2009, the weighted average remaining contractual life of options outstanding is 2.39 years (1.04 years for options exercisable).  The aggregate intrinsic value of options outstanding and options exercisable is $1.6 million and $1.0 million, respectively and unrecognized compensation cost related to stock options outstanding on Inter Parfums, Inc. stock aggregated $1.4 million. The amount of unrecognized compensation cost related to stock options outstanding of our majority-owned subsidiary, Inter Parfums S.A., was €0.2 million. Options under Inter Parfums, S.A. plans vest over a four-year period and no options were granted by Inter Parfums, S.A. during the nine month periods ended September 30, 2009 and 2008.

 
Page 11

 
INTER PARFUMS, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements
 
Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the nine month periods ended September 30, 2009 and September 30, 2008 were as follows:
 
(In thousands)
 
September 30,
 2009
   
September 30,
 2008
 
Cash proceeds from stock options exercised
  $ 55     $ 272  
Tax benefits
    145       207  
Intrinsic value of stock options exercised
    11       136  

The weighted average fair values of the options granted by Inter Parfums, Inc. during the nine months ended September 30, 2009 and 2008 were $1.92 and $3.69 per share, respectively, on the date of grant using the Black-Scholes option pricing model to calculate the fair value of options granted. The assumptions used in the Black-Scholes pricing model for the periods ended September 30, 2009 and 2008 are set forth in the following table:

   
September 30,
 2009
   
September 30,
 2008
 
             
Weighted-average expected stock-price volatility
    46 %     39 %
Weighted-average expected option life
 
3.75 years
   
4.5 years
 
Weighted-average risk-free interest rate
    1.74 %     2.7 %
Weighted-average dividend yield
    2.20 %     1.20 %

Expected volatility is estimated based on historic volatility of the Company’s common stock. The Company uses the simplified method in developing its estimate of the expected term of the option as historic data regarding employee exercise behavior is incomplete for the new vesting parameters recently instituted by the Company. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of the grant of the option and the dividend yield reflects the assumption that the dividend payout in place at the time of stock-based award grant would continue with no anticipated increases.

8.
Earnings Per Share:

Basic earnings per share is computed using the weighted average number of shares outstanding during each period. Diluted earnings per share is computed using the weighted average number of shares outstanding during each period, plus the incremental shares outstanding assuming the exercise of dilutive stock options and warrants using the treasury stock method. The following table sets forth the computation of basic and diluted earnings per share:

 
 
Three months ended
September 30,
   
Nine months ended
September 30,
 
(In thousands)
 
2009
   
2008
   
2009
   
2008
 
Numerator:
                       
Net income attributable to Inter Parfums, Inc.
  $ 7,262     $ 6,188     $ 16,916     $ 18,668  
Effect of dilutive securities of consolidated subsidiary
          (35 )     (18 )     (122 )
                                 
    $ 7,262     $ 6,153     $ 16,898     $ 18,546  
Denominator:
                               
Weighted average shares
    30,061       30,632       30,097       30,660  
Effect of dilutive securities:
                               
Stock options and warrants
    4       254       1       209  
                                 
      30,065       30,886       30,098       30,869  

 
Page 12

 
INTER PARFUMS, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements
 
Not included in the above computations is the effect of antidilutive potential common shares which consist of outstanding options to purchase 1.0 million and 1.1 million shares of common stock for the three and nine month periods ended September 30, 2009, and 0.3 million and 0.4 million shares of common stock for the three and nine month periods ended September 30, 2008, respectively, as well as outstanding warrants to purchase 300,000 shares of common stock for both the three and nine month periods ended September 30, 2009 and 150,000 shares of common stock for both the three and nine month periods ended September 30, 2008.

9.
Comprehensive Income (Loss):

 
 
Three months ended
September 30,
   
Nine months ended
September 30,
 
(In thousands)
 
2009
   
2008
   
2009
   
2008
 
Comprehensive income (loss):
                       
Net income
  $ 9,611     $ 7,879     $ 22,620     $ 23,506  
Other comprehensive income, net of tax:
                               
Foreign currency translation adjustment
    9,049       (17,134 )     13,251       (5,436 )
Change in fair value of derivatives
    (1,148 )     (7 )     (1,919 )     (193 )
Net gains reclassified into earnings from equity
    (751 )           (2,329 )      
Comprehensive income (loss):
    16,761       (9,262 )     31,623       17,877  
Less comprehensive income (loss) attributable to the noncontrolling interest
    1,832       1,684       4,620       4,785  
                                 
Comprehensive income (loss) attributable to Inter Parfums, Inc.
  $ 14,929     $ (10,946 )   $ 27,003     $ 13,092  

10.
Net Income Attributable to Inter Parfums, Inc. and Transfers From the Noncontrolling Interest:

 
 
Three months ended
September 30,
   
Nine months ended
September 30,
 
(In thousands)
 
2009
   
2008
   
2009
   
2008
 
                         
Net income attributable to Inter Parfums, Inc.
  $ 7,262     $ 6,188     $ 16,916     $ 18,668  
Increase (decrease) in Inter Parfums, Inc.’s additional paid-in capital for subsidiary share transactions
    (36 )       18       (53 )       215  
Change from net income attributable to Inter Parfums, Inc. and transfers from noncontrolling interest
  $  7,226     $  6,206     $  16,863     $  18,883  

11.
Segment and Geographic Areas:

 
We manufacture and distribute one product line, fragrances and fragrance related products and we manage our business in two segments, European based operations and United States based operations. The European assets are primarily located, and operations are primarily conducted, in France. European operations primarily represent the sale of prestige brand name fragrances and United States operations primarily represent the sale of specialty retail and mass market fragrances. Information on the Company’s operations by geographical areas is as follows:

 
Page 13

 
INTER PARFUMS, INC. AND SUBSIDIARIES
 
Notes to Consolidated Financial Statements
 
 
 
Three months ended
September 30,
   
Nine months ended
September 30,
 
(In thousands) 
 
2009
   
2008
   
2009
   
2008
 
Net sales:
                       
United States
  $ 13,541     $ 14,714     $ 31,150     $ 42,467  
Europe
    104,001       109,479       265,405       304,983  
Eliminations of intercompany sales
          (662 )           (1,678 )
                                 
    $ 117,542     $ 123,531     $ 296,555     $ 345,772  
                                 
Net income (loss) attributable to Inter Parfums, Inc.:
                               
United States
  $ 288     $ 189     $ (1,057 )   $ 412  
Europe
    6,969       5,980       17,941       18,252  
Eliminations of intercompany profits
    5       19       32       4  
                                 
    $ 7,262     $ 6,188     $ 16,916     $ 18,668  

   
September 30,
   
December 31,
 
   
2009
   
2008
 
Total Assets:
           
United States
  $ 49,693     $ 56,320  
Europe
    380,924       380,058  
Eliminations of investment in subsidiary
    (9,182 )     (11,241 )
                 
    $ 421,435     $ 425,137  

12.
Entry Into Definitive Agreements:

In October 2009, we entered into an exclusive worldwide license agreement with J Choo Limited for the creation, development and distribution of fragrances under the Jimmy Choo brand. Our rights under such license agreement, which runs through 2022, are subject to certain minimum sales, advertising expenditures and royalty payments as are customary in our industry. A member of the Company’s board of directors is also a member of the board of directors of Jimmy Choo Limited.

13.
Subsequent Events:

 
We evaluated subsequent events through November 9, 2009, the date this Quarterly report was filed with the Securities and Exchange Commission.
 
Page 14

INTER PARFUMS, INC. AND SUBSIDIARIES
 
Item 2:
MANAGEMENT’S DISCUSSION AND ANALYSIS OFFINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward Looking Information

Statements in this report which are not historical in nature are forward-looking statements. Although we believe that our plans, intentions and expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such plans, intentions or expectations will be achieved. In some cases you can identify forward-looking statements by forward-looking words such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "should," "will" and "would" or similar words. You should not rely on forward-looking statements because actual events or results may differ materially from those indicated by these forward-looking statements as a result of a number of important factors. These factors include, but are not limited to, the risks and uncertainties discussed under the headings “Forward Looking Statements” and "Risk Factors" in Inter Parfums' annual report on Form 10-K for the fiscal year ended December 31, 2008 and the reports Inter Parfums files from time to time with the Securities and Exchange Commission. Inter Parfums does not intend to and undertakes no duty to update the information contained in this report.
 
Overview

We operate in the fragrance business, and manufacture, market and distribute a wide array of fragrances and fragrance related products. We manage our business in two segments, European based operations and United States based operations. Our prestige fragrance products are produced and marketed by our European operations through our 75% owned subsidiary in Paris, Inter Parfums, S.A., which is also a publicly traded company as 25% of Inter Parfums, S.A. shares trade on the Euronext. Prestige cosmetics and prestige skin care products currently represent less than 3% of consolidated net sales.

We produce and distribute our prestige products primarily under license agreements with brand owners and European based prestige product sales represented 89% and 88% of net sales for the nine months ended September 30, 2009 and 2008, respectively. We have built a portfolio of brands, which include Burberry, Lanvin, Van Cleef & Arpels, Jimmy Choo, Paul Smith, S.T. Dupont and Nickel whose products are distributed in over 120 countries around the world. Burberry is our most significant license; sales of Burberry products represented 58% and 56% of net sales for the nine months ended September 30, 2009 and 2008, respectively.

In September 2009, by mutual consent as a result of unsatisfactory commercial development, we agreed to an early termination of our license agreement with Quiksilver. The termination will take effect on June 30, 2010 and is not expected to have any material effect on our consolidated financial statements.

Our specialty retail and mass-market fragrance and fragrance related products are marketed through our United States operations and represented 11% and 12% of net sales for the nine months ended September 30, 2009 and 2008, respectively. These products are sold under trademarks owned by us or pursuant to license or other agreements with the owners of the Gap, Banana Republic, New York & Company, Brooks Brothers, bebe and Jordache trademarks.

 
Page 15

 
INTER PARFUMS, INC. AND SUBSIDIARIES

Historically, seasonality has not been a major factor for our Company. However, with the commencement of operations in 2007 of our four majority-owned European distribution subsidiaries and direct to retailer shipments of our specialty retail product lines, sales are more concentrated in the second half of the year.
 
We grow our business in two distinct ways. First, we grow by adding new brands to our portfolio, either through new licenses or out-right acquisitions of brands. Second, we grow through the introduction of new products and supporting new and established products through advertising, merchandising and sampling as well as phasing out existing products that no longer meet the needs of our consumers. The economics of developing, producing, launching and supporting products influence our sales and operating performance each year.  Our introduction of new products may have some cannibalizing effect on sales of existing products, which we take into account in our business planning.

Our business is not capital intensive, and it is important to note that we do not own manufacturing facilities. We act as a general contractor and source our needed components from our suppliers. These components are received at one of our distribution centers and then, based upon production needs, the components are sent to one of several third party fillers which manufacture the finished good for us and ship it back to our distribution center.

As with any business, many aspects of our operations are subject to influences outside our control.  These factors include the effect of the current financial crisis and therefore the potential for further deterioration in consumer spending and consumer debt levels, as well as the continued availability of favorable credit sources and capital market conditions in general. The recent economic challenges and uncertainties in a number of countries where we do business, including the United States, have impacted our business. This financial crisis is global in scale and has negatively affected consumer demand, which is having an adverse impact on our distributors and our retail customers. These events have led distributors and retailers to carry less inventory than usual and have resulted in changes in their ordering patterns for the products that we sell.  Although some signs of a recovery have become apparent with improving sales trends, the impact of this financial crisis has been challenging for us thus far this year and is expected to continue to be challenging for the remainder of 2009.
 
We have reviewed our plans and have taken actions to mitigate the impact of these conditions. We have adjusted, and we are continuing to adjust our advertising and promotional budgets to align our spending with anticipated sales. In addition, we have implemented cost saving initiatives to right size our staff in an effort to maintain long-term profitable growth. As part of our strategy, we plan to continue to make investments behind fast-growing markets and channels to grow market share. While our business strategies are designed to strengthen our Company over the long-term, we believe the uncertainty about future market conditions, consumer spending patterns and the financial strength of some of our customers could negatively affect our net sales and operating results.

In addition to the ongoing global financial crisis, our reported net sales in comparison to the corresponding periods of the prior year have been negatively impacted by changes in foreign currency exchange rates. A strong U.S. dollar has an adverse impact on our net sales, as a substantial portion of sales of our European operations are denominated in euro.

 
Page 16

 
INTER PARFUMS, INC. AND SUBSIDIARIES

Recent Important Events

Jimmy Choo

In October 2009, we entered into an exclusive worldwide license agreement with J Choo Limited for the creation, development and distribution of fragrances under the Jimmy Choo brand. Our rights under such license agreement, which runs through 2022, are subject to certain minimum sales, advertising expenditures and royalty payments as are customary in our industry. Plans call for our first Jimmy Choo fragrance launch in late 2010 or in 2011.

bebe Stores, Inc.

In July 2008, we entered into an exclusive six year worldwide agreement with bebe Stores, Inc. under which we design, manufacture and supply fragrance, bath and body products and color cosmetics for company-owned bebe stores in the United States and Canada as well as select specialty and department stores worldwide.

Gap and Banana Republic International

In April 2008, we expanded our current relationship with Gap Inc. with the signing of a licensing agreement for international distribution of personal care products through Gap and Banana Republic stores as well as select specialty and department stores outside the United States, including duty-free and other travel related retailers. The agreement is effective through December 31, 2011.

Discussion of Critical Accounting Policies

We make estimates and assumptions in the preparation of our financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ significantly from those estimates under different assumptions and conditions. We believe the following discussion addresses our most critical accounting policies, which are those that are most important to the portrayal of our financial condition and results of operations. These accounting policies generally require our management’s most difficult and subjective judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain.

The judgments used by management in applying critical accounting policies could be affected by a further and prolonged general deterioration in the economic environment, which could negatively influence future financial results and availability of continued financing. Specifically, subsequent evaluations of our accounts receivables, inventories, and deferred tax assets in light of the factors then prevailing, could result in significant changes in our allowance and reserve accounts in future periods which in turn could generate significant additional charges. Similarly, the valuation of certain intangible assets could be negatively impacted by prolonged and severely depressed market conditions thus leading to the recognition of impairment losses. The following is a brief discussion of the more critical accounting policies that we employ.

 
Page 17

 
INTER PARFUMS, INC. AND SUBSIDIARIES

Revenue Recognition

We sell our products to department stores, perfumeries, specialty retailers, mass-market retailers, supermarkets and domestic and international wholesalers and distributors. Sales of such products by our domestic subsidiaries are denominated in U.S. dollars and sales of such products by our foreign subsidiaries are primarily denominated in either Euros or U.S. dollars. Accounts receivable reflect the granting of credit to these customers. We generally grant credit based upon our analysis of the customer’s financial position as well as previously established buying patterns. We recognize revenues when merchandise is shipped and the risk of loss passes to the customer. Net sales are comprised of gross revenues less returns, trade discounts and allowances.

Sales Returns

Generally, we do not permit customers to return their unsold products. However, on a case-by-case basis we occasionally allow customer returns. We regularly review and revise, as deemed necessary, our estimate of reserves for future sales returns based primarily upon historic trends and relevant current data. We record estimated reserves for sales returns as a reduction of sales, cost of sales and accounts receivable. Returned products are recorded as inventories and are valued based upon estimated realizable value. The physical condition and marketability of returned products are the major factors we consider in estimating realizable value. Actual returns, as well as estimated realizable values of returned products, may differ significantly, either favorably or unfavorably, from our estimates, if factors such as economic conditions, inventory levels or competitive conditions differ from our expectations.

Promotional Allowances

We have various performance-based arrangements with certain retailers. These arrangements primarily allow customers to take deductions against amounts owed to us for product purchases. The costs that our Company incurs for performance-based arrangements, shelf replacement costs and slotting fees are netted against revenues on our Company’s consolidated statement of income. Estimated accruals for promotions and advertising programs are recorded in the period in which the related revenue is recognized. We review and revise the estimated accruals for the projected costs for these promotions. Actual costs incurred may differ significantly, either favorably or unfavorably, from estimates if factors such as the level and success of the retailers’ programs or other conditions differ from our expectations.

Inventories

Inventories are stated at the lower of cost or market value. Cost is principally determined by the first-in, first-out method. We record adjustments to the cost of inventories based upon our sales forecast and the physical condition of the inventories. These adjustments are estimates, which could vary significantly, either favorably or unfavorably, from actual requirements if future economic conditions or competitive conditions differ from our expectations.

 
Page 18

 
INTER PARFUMS, INC. AND SUBSIDIARIES

Equipment and Other Long-Lived Assets

Equipment, which includes tools and molds, is recorded at cost and is depreciated on a straight-line basis over the estimated useful lives of such assets. Changes in circumstances such as technological advances, changes to our business model or changes in our capital spending strategy can result in the actual useful lives differing from our estimates. In those cases where we determine that the useful life of equipment should be shortened, we would depreciate the net book value in excess of the salvage value, over its revised remaining useful life, thereby increasing depreciation expense. Factors such as changes in the planned use of equipment, or market acceptance of products, could result in shortened useful lives.

We evaluate goodwill and indefinite-lived intangible assets for impairment at least annually during the fourth quarter, or more frequently when events occur or circumstances change, such as an unexpected decline in sales, that would more likely than not (i) reduce the fair value of the reporting unit below its fair value or (ii) indicate that the carrying value of an indefinite-lived intangible asset may not be recoverable.  Impairment of goodwill is evaluated using a two step process. The first step involves a comparison of the estimated fair value of the reporting unit to the carrying value of that unit. If the carrying value of the reporting unit exceeds the fair value of the reporting unit, the second step of the process involves comparison of the implied fair value of goodwill (based on industry purchase and sale transaction data) with its carrying value. If the carrying value of the reporting unit’s goodwill exceeds the implied fair value of that goodwill, an impairment loss is recognized as an amount equal to the excess. For indefinite-lived intangible assets, the evaluation requires a comparison of the estimated fair value of the asset to the carrying value of the asset. If the carrying value of an indefinite-lived intangible asset exceeds its fair value, impairment is recorded.

Goodwill relates to our Nickel skin care business, which is primarily a component of our European operations. Testing goodwill for impairment requires us to estimate the fair value of the reporting unit using significant estimates and assumptions. The assumptions we make will impact the outcome and ultimate results of the testing. In making our assumptions and estimates, we use industry accepted valuation models and set criteria that are reviewed and approved by management and, in certain instances, we engage third party valuation specialists to advise us. The first step of our goodwill impairment evaluation has given rise to potential impairment indicators and, as a result of continued sales declines, we test for impairment of goodwill on a quarterly basis. We have measured fair value of goodwill as a multiple of sales applied to the average of 2008 actual sales and projected sales for 2009 and 2010, which we believe is representative of the current state of the reporting unit. We expect Nickel brand sales to decline approximately 5% in 2009 as the global economic crisis continues, and we expect Nickel brand sales to increase 5% in 2010 as the result of new product launches in combination with an expected economic recovery. In estimating future sales, we use our internal budgets developed based on recent sales data for existing products and planned timing of new product launches. The sales multiple is based on a third party financial institution study of sales multiples for all transactions in the skin care, perfume and cosmetic sectors during the past four years. At current exchange rates, if average sales for the reporting unit decreased 10% we would incur a goodwill impairment charge of $1.0 million.

 
Page 19

 

INTER PARFUMS, INC. AND SUBSIDIARIES

To determine fair value of indefinite-lived intangible assets, we use an income approach, including the relief-from-royalty method. This method assumes that, in lieu of ownership, a third party would be willing to pay a royalty in order to obtain the rights to use the comparable asset. The relief-from-royalty calculations require us to make a number of assumptions and estimates concerning future sales levels, market royalty rates, future tax rates and discount rates. We use this method to determine if an impairment charge is required relating to our Nickel brand trademarks. During the three month period ended June 30, 2009, an impairment charge relating to the Nickel trademark in the amount of $0.26 million was recorded. No additional impairment during the three months ended September 30, 2009 was needed. We assumed a market royalty rate of 6% and a discount rate of 9.5%. The following table presents the impact a change in the following significant assumptions would have had on our impairment charge recognized at June 30, 2009 assuming all other assumptions remained constant:

In thousands
       
Increase (decrease)
 
   
Change
   
to impairment charge
 
             
Weighted average cost of capital
   
+10%
    $
(181)
 
Weighted average cost of capital
   
-10%
    $
226
 
Future sales levels
 
 
+10%
    $
264
 
Future sales levels
   
-10%
    $
(264)
 

The fair values used in our evaluations are also estimated based upon discounted future cash flow projections using a weighted average cost of capital of 9.5%. The cash flow projections are based upon a number of assumptions, including, future sales levels and future cost of goods and operating expense levels, as well as economic conditions, changes to our business model or changes in consumer acceptance of our products which are more subjective in nature. We believe that the assumptions that we have made in projecting future cash flows for the evaluations described above are reasonable and currently no impairment indicators exist for our indefinite-lived assets other than the Nickel trademarks referred to above. However, if future actual results do not meet our expectations, we may be required to record an impairment charge, the amount of which could be material to our results of operations.

Intangible assets subject to amortization are evaluated for impairment testing whenever events or changes in circumstances indicate that the carrying amount of an amortizable intangible asset may not be recoverable. If impairment indicators exist for an amortizable intangible asset, the undiscounted future cash flows associated with the expected service potential of the asset are compared to the carrying value of the asset. If our projection of undiscounted future cash flows is in excess of the carrying value of the intangible asset, no impairment charge is recorded. If our projection of undiscounted future cash flows is less than the carrying value of the intangible asset, an impairment charge would be recorded to reduce the intangible asset to its fair value. The cash flow projections are based upon a number of assumptions, including future sales levels and future cost of goods and operating expense levels, as well as economic conditions, changes to our business model or changes in consumer acceptance of our products which are more subjective in nature. We believe that the assumptions we have made in projecting future cash flows for the evaluations described above are reasonable and currently no impairment indicators exist for our intangible assets subject to amortization. In those cases where we determine that the useful life of long-lived assets should be shortened, we would depreciate the net book value in excess of the salvage value (after testing for impairment as described above), over the revised remaining useful life of such asset thereby increasing amortization expense.

 
Page 20

 

INTER PARFUMS, INC. AND SUBSIDIARIES

In determining the useful life of our Lanvin brand names and trademarks, we applied the provisions of ASC topic 350-30-35-3 (formerly paragraph 11 of SFAS 142). The only factor that prevented us from determining that the Lanvin brand names and trademarks were indefinite life intangible assets was Item c. “Any legal, regulatory, or contractual provisions that may limit the useful life”. The existence of a repurchase option in 2025 may limit the useful life of the Lanvin brand names and trademarks to the company. However, this limitation would only take effect if the repurchase option were to be exercised and the repurchase price was paid. If the repurchase option is not exercised, then the Lanvin brand names and trademarks are expected to continue to contribute directly to the future cash flows of our company and their useful life would be considered to be indefinite.

With respect to the application of ASC topic 350-30-35-8 (formerly paragraph 13 of SFAS 142), the Lanvin brand names and trademarks would only have a finite life to our company if the repurchase option were exercised, and in applying ASC topic 350-30-35-8 we assumed that the repurchase option is exercised. When exercised, Lanvin has an obligation to pay the exercise price and the company would be required to convey the Lanvin brand names and trademarks back to Lanvin. The exercise price to be received (Residual Value) is well in excess of the carrying value of the Lanvin brand names and trademarks, therefore no amortization is required.

Derivatives

We account for derivative financial instruments in accordance with ASC topic 815 (formerly SFAS No. 133, “Accounting for Derivative Instruments and Hedging Activities,” as amended), which establish accounting and reporting standards for derivative instruments, including certain derivative instruments embedded in other contracts, and for hedging activities.  This topic also requires the recognition of all derivative instruments as either assets or liabilities on the balance sheet and that they are measured at fair value.
 
We currently use derivative financial instruments to hedge certain anticipated transactions and interest rates, as well as receivables denominated in foreign currencies.  We do not utilize derivatives for trading or speculative purposes.  Hedge effectiveness is documented, assessed and monitored by employees who are qualified to make such assessments and monitor the instruments.  Variables that are external to us such as social, political and economic risks may have an impact on our hedging program and the results thereof. 

Income Taxes